We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$822M
AUM Growth
+$213M
Cap. Flow
+$159M
Cap. Flow %
19.35%
Top 10 Hldgs %
48.5%
Holding
184
New
56
Increased
30
Reduced
32
Closed
61

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$30.7M
2
ZEN
ZENDESK INC
ZEN
+$15.8M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$15.4M
4
MSFT icon
Microsoft
MSFT
+$15.2M
5
SMAR
Smartsheet Inc.
SMAR
+$13M

Sector Composition

Rank Sector Weight
1 Technology 29.02%
2 Healthcare 12.33%
3 Communication Services 6.21%
4 Utilities 5.54%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YTRA icon
176
Yatra Online
YTRA
$54M
-160,000
Closed -$309K
LGF.A
177
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-34,500
Closed -$392K
ZUO
178
DELISTED
Zuora, Inc.
ZUO
-20,000
Closed -$279K
EVA
179
DELISTED
Enviva Inc.
EVA
-248,800
Closed -$11.3M
HCARU
180
DELISTED
Healthcare Services Acquisition Corporation Unit
HCARU
-47,500
Closed -$485K
IEAWW
181
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
-1,199,327
Closed -$3.78M
JE
182
DELISTED
Just Energy Group Inc
JE
-450,000
Closed -$2.11M
BHVN
183
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-500
Closed -$43K
BHVN
184
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-1,500
Closed -$129K

Similar funds

Ardsley Advisory Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Ardsley Advisory Partners held 184 positions worth $822M, up 35% from $609M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Ardsley Advisory Partners deployed $159M of net new capital in Q1 2021, opening 56 new positions and adding to 30 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 70,000 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was SunOpta, an estimated $19.9M trimmed.

  • Ardsley Advisory Partners's largest Q1 2021 buy was Vertex Pharmaceuticals: 70,000 shares worth $15M.
  • Ardsley Advisory Partners added most to Baidu in Q1 2021, an estimated $30.7M increase.
  • Ardsley Advisory Partners's biggest Q1 2021 reduction was SunOpta, cutting an estimated $19.9M.
  • Ardsley Advisory Partners fully exited Enviva Inc. in Q1 2021, selling an estimated $11.3M.
  • Ardsley Advisory Partners's ten largest holdings make up 48% of its $822M portfolio in Q1 2021.
  • Ardsley Advisory Partners opened 56 new positions and closed 61 in Q1 2021.
  • Ardsley Advisory Partners's portfolio value rose 35% quarter-over-quarter to $822M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2021, filed 17 May 2021.